2015 – #64 – BioSyent

Licenses and acquires pharmaceutical products to bring to market in Canada


Company Profile

Founded 2006
Chief Executives René Goehrum
Head Office Toronto
Website www.biosyent.com
Stock Ticker TSX-V:RX


Company Financials

5-Year Growth 1,086
Revenue Range 10–19.9 million
Reporting Curency CAD
Exports as % of Sales 4
Employees 2014: 27
Revenue 2013 (actual): N/A


Read More

Comments are closed.